Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery- Rein 3D Anxiety
Launched by UNIVERSITY HOSPITAL, BORDEAUX · Sep 5, 2023
Trial Information
Current as of August 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Rein 3D Anxiety study, is looking at how using a personalized three-dimensional (3D) model of a patient's kidney tumor can help reduce anxiety before surgery. Specifically, the study compares three types of pre-operative information: viewing a 3D virtual model, handling a 3D printed model, and receiving standard information. The goal is to see if these methods can make patients feel less anxious the day before they undergo nephron-sparing surgery, which is a procedure to remove a kidney tumor while preserving as much healthy kidney tissue as possible.
To participate in this trial, you need to be an adult who is scheduled for laparoscopic partial nephrectomy (a type of surgery for kidney tumors) and have a unilateral kidney tumor or be having your first surgery for a bilateral condition. Additionally, you must be able to give your consent and understand the information provided in French. If you join the study, you can expect to learn more about your condition through the 3D models and see if this approach helps ease your anxiety before surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (≥ 18 years of age)
- • Scheduled surgical management by laparoscopic partial nephrectomy with robotic assistance for kidney tumor
- • Unilateral kidney tumor or 1st surgery for bilateral involvement
- • Consent expressed for integration of the UroCCR cohort,
- • Expressed consent for participation in the 3D Anxiety study.
- • Patients affiliated or benefiting from a social security plan
- Exclusion Criteria:
- • Refusal of consent or participation
- • Difficulty understanding and expressing oneself in French
- • Patient under guardianship or curatorship
- • No preoperative CT scan available for 3D modeling
About University Hospital, Bordeaux
The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nantes, , France
Caen, , France
Angers, , France
Bordeaux, , France
Marseille, , France
Caen, Calvados, France
Le Kremlin Bicêtre, , France
Patients applied
Trial Officials
Jean-Christophe BERNHARD, Professeur
Principal Investigator
University Hospital, Bordeaux
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported